FDA Office of Pharmaceutical Sciences Deputy Director Eric Sheinin
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Will join the U.S. Pharmacopeia as VP-general policy & requirements at the end of February. Sheinin, PhD, will retire from FDA Feb. 10. A replacement has not yet been name